Step Mary M MM - OmicsDI

Show results for

Proteomics (22)
Transcriptomics (7)
Unknown (5)
Metabolomics (4)
Genomics (2)

Organisms

Homo sapiens (19)
Mus musculus (10)
Ruegeria pomeroyi DSS-3 (1)
mixed sample (1)
Danio rerio (1)
Equus caballus (1)
Plasmodium vivax Sal-1 (1)
Saimiri boliviensis boliviensis (1)

Repository

pride (22)
biostudies-arrayexpress (7)
MetaboLights (4)
EGA (2)

Tissue

Cell culture (9)
Permanent cell line cell (5)
Epithelial cell (4)
Blood cell (3)
Dendritic cell (2)
Fibroblast (2)
HeLa cell (2)
Myeloid cell (2)
Acute myeloid leukemia cell (1)
Acute myeloid leukemia cell line (1)
B cell (1)
Brain (1)
Cell suspension culture (1)
Embryonic stem cell (1)
Endothelial cell (1)
Enterocyte (1)
Epithelial cell of esophagus (1)
Erythrocyte (1)
Esophageal epithelial cell (1)
Extracellular matrix secreting cell (1)
Granulocyte (1)
Haematopoietic stem cells (1)
Hepatocyte (1)
Kidney (1)
Leukocyte (1)
Lymphoblast (1)
Lymphoblastic leukemia cell line (1)
Macrophage (1)
Monocyte (1)
T cell (1)

Disease

Acute myeloid leukemia (4)
Colon cancer (3)
Disease free (3)
Cervix carcinoma (2)
Acute leukemia (1)
Alveolar rhabdomyosarcoma (1)
Brain cancer (1)
Breast cancer (1)
Embryonal rhabdomyosarcoma (1)
Esophageal cancer (1)
Hepatocellular carcinoma (1)
Myeloid leukemia (1)
Pancreatic ductal adenocarcinoma (1)
Pelger-Huet anomaly (1)
Plasmodium vivax malaria (1)
Rhabdomyosarcoma (1)

Technology Type

Mass Spectrometry (22)
Shotgun proteomics (15)
Affinity purification coupled with mass spectrometry proteomics (5)
Mass spectrometry (4)
Top-down proteomics (3)
Bottom-up proteomics (2)
Data-dependent acquisition (2)
Gel-based experiment (1)

Instrument Platform

Scanning hardware (2)
Flow Injection Analysis MS - Alternating (FIA-MS (Alternating)) (2)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (2)
Liquid Chromatography MS - positive - reverse phase (2)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2023 (8)
2021 (6)
2026 (3)
2014 (2)
2005 (2)
2024 (2)
2020 (2)
2017 (2)
2009 (1)
2007 (1)
2019 (1)
2018 (1)
2022 (1)
2016 (1)

CHEBI ID

CHEBI:15428 (2)
CHEBI:15727 (2)
CHEBI:15746 (2)
CHEBI:15891 (2)
CHEBI:16449 (2)
CHEBI:16610 (2)
CHEBI:16737 (2)
CHEBI:16811 (2)
CHEBI:17126 (2)
CHEBI:17148 (2)
CHEBI:17822 (2)
CHEBI:17929 (2)
CHEBI:18095 (2)
CHEBI:18133 (2)
CHEBI:18186 (2)
CHEBI:18211 (2)
CHEBI:18237 (2)
CHEBI:18243 (2)
CHEBI:18257 (2)
CHEBI:18295 (2)
CHEBI:22653 (2)
CHEBI:22660 (2)
CHEBI:24898 (2)
CHEBI:25017 (2)
CHEBI:25094 (2)
CHEBI:26271 (2)
CHEBI:26986 (2)
CHEBI:27266 (2)
CHEBI:27570 (2)
CHEBI:27897 (2)

Metabolite Name

ADMA (2)
Ac-Orn (2)
Ala (2)
Arg (2)
Asn (2)
Asp (2)
Carnosine (2)
Cit (2)
Creatinine (2)
DOPA (2)
Dopamine (2)
Gln (2)
Glu (2)
Gly (2)
His (2)
Histamine (2)
Ile (2)
Kynurenine (2)
Leu (2)
Lys (2)
Met (2)
Met-SO (2)
Nitro-Tyr (2)
Orn (2)
PEA (2)
Phe (2)
Pro (2)
Putrescine (2)
SDMA (2)
Ser (2)

Study type

Transcription profiling by array (5)
Cell line - One-color microarray (1)
Other (1)

Release Date

2021 (2)
2014 (2)
2005 (2)
2022 (2)
2009 (1)
2007 (1)
2020 (1)
2015 (1)

Lab affiliation

Centre for Cancer Cell & Molecular Biology Barts Cancer Institute Queen Mary University of London Charterhouse Square London EC1M 6BQ U.K. (3)
Blizard Institute, Centre for Genomics and Child Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK (2)
1. Barts Cancer Institute Queen Mary, University of London John Vane Science Centre, Charterhouse Square, London EC1M 6BQ 2. Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, 18016, Spain (1)
Associate Professor, University College Dublin, School of Biomolecular and Biomedical Science, Conway Institute Belfield Dublin 4 (1)
Barts Cancer Institute, Queen Mary University of London (1)
Barts Cancer Institute. Queen Mary University of London (1)
Cell Signaling and Proteomics Group, Center for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK. (1)
Cell Signalling & Proteomics Group, Centre for Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK (1)
Cell Signalling and Proteomics Group, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom (1)
Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse square, London EC1M 6BQ, United Kingdom. (1)
Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary Universty of London (1)
Centre for Genomics and Computational Biology. Barts Cancer Institute / Queen Mary University of London (1)
Centre for Haemato-Oncology Barts Cancer Institute Queen Mary, University of London (1)
Department of Biochemistry and Molecular Biology Bio21 Molecular Science and Biotechnology Institute Third floor, room 368 The University of Melbourne Victoria 3010 Australia (1)
Department of Chemistry, Wayne State University, 5101 Cass Avenue, Detroit, MI 48202 (1)
Division of Pediatric Hematology and Oncology, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Switzerland (1)
Emory University (1)
Institute of Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, Mile End Road, London, E1 4NS, UK (1)
Reader in Centre for Genomics and Computational Biology Barts Cancer Institute Queen Mary, University of London John Vane Science Centre, Charterhouse Square, London EC1M 6BQ Tel: +44 (0)20 7882 8266 | Fax: +44 (0)20 7882 3891 | Email: p.cutillas@qmul.ac.uk www.bci.qmul.ac.uk/research/centre-profiles/haemato-oncology.html https://www.bci.qmul.ac.uk/en/staff/item/pedro-cutillas (1)

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

Global gene expression of Ruegeria pomeroyi DSS-3 during ammonium-limited, ribose phosphate-, methylphosphonate-, or potassium phosphate-excess growth regimes or during potassium phosphate-limited, ammonium-excess regime

We used the previously designed oligonucleotide microarrays (BM-CM-

ORGANISM(S): Ruegeria pomeroyi DSS-3

2014-06-02 | E-GEOD-38740 | biostudies-arrayexpress

MaHPIC Experiment E03 - Quantitative Metabolomics of Macaca mulatta infected with Plasmodium coatneyi Hackeri strain to produce and integrate clinical, hematological, parasitological, and omics measures of acute, recrudescent, and chronic infections

MaHPIC Experimental Description:
Malaria-naive male rhesus macaques (Macaca mulatta), approximately four years of age, were inoculated intravenously with salivary gland sporozoites produced and isolated at the Centers for Disease Control and Prevention from multiple Anopheles

2018-09-05 | MTBLS691 | MetaboLights

Cyclophilin A isomerization of Septin 2 mediates abscission during cytokinesis

The isomerase activity of Cyclophilin A is important for midbody abscission during cell division, however to date, midbody substrates remain unknown. In this study, we report that the GTP-binding protein Septin 2 interacts with Cyclophilin A. We highlight a dynamic series of Septin 2 phenotypes at t...

ORGANISM(S): Homo sapiens (Human)

2023-10-24 | PXD042822 | Pride

Identification of cis-regulatory modules for adeno-associated virus-based cell-type-specific targeting in the retina and brain.

Not available

S-EPMC8980332 | biostudies-literature

HDAC11 Deacetylates BRAF to Regulate Kinase Activity and Cell Proliferation

Histone acetylation, governed by histone deacetylase (HDAC) enzymes, plays a pivotal role in cell biology. Elevated HDAC expression is linked to poor prognosis in various diseases, including cancer, making HDAC inhibitors clinically valuable. Among the 11 metal-dependent HDAC isoforms, the exception...

ORGANISM(S): Homo sapiens (Human)

2026-04-27 | PXD066596 | Pride

Proteomics Braf Substrate profiling Kinase activity Histone deacetylase Hdac11

MaHPIC Experiment 07A and 07B: Quantitative Metabolomics from Macaca fascicularis infected with Plasmodium knowlesi sporozoites to produce and integrate clinical, hematological, parasitological, omics, telemetric and histopathological measures of acute primary infection

E07 was originally planned and implemented prior to E06. The E07 cohort was inoculated with freshly dissected P. knowlesi sporozoites on 11/01/16. However, for unexplained reasons blood-stage parasitemias did not occur. Consequently, the E07 cohort was reinoculated with cryopreserved P. kn...

2019-01-11 | MTBLS822 | MetaboLights

Emerald ash borer (Agrilus planipennis) infestation bioassays and metabolic profiles of green ash (Fraxinus pennsylvanica) provide evidence for an induced host defensive response to larval infestation

INTRODUCTION: Larvae of the invasive emerald ash borer [EAB, Agrilus planipennis Fairmaire (Coleoptera: Buprestidae)], kill over 99% of green ash (Fraxinus pennsylvanica Marshall) trees they infest, yet a small percentage of green ash (“linge...

2024-02-08 | MTBLS7999 | MetaboLights

PhyloChip-based characterization of wastewater reactors

We developed a laboratory-scale model to improve our understanding and capacity to assess the biological risks of genetically engineered bacteria and their genetic elements in the natural environment. Our hypothetical scenario concerns an industrial bioreactor failure resulting in the introduction ...

ORGANISM(S): mixed sample

2014-06-06 | E-GEOD-58251 | biostudies-arrayexpress

Effect of the Src inhibitor peptide TAT-Cx43266-283 in lung cancer brain metastasis models.

Background: TAT-Cx43266-283 is a novel inhibitor of Src, which has shown important antitumor effects in preclinical models of glioblastoma. Because Src plays a pivotal role in several tumors, including lung cancer and brain metastasis, in this study we investigated the effect of TAT-Cx43266-283 in l...

ORGANISM(S): Mus musculus (Mouse)

2026-03-02 | PXD058276 | Pride

Cancer stem cells Metastasis Src Tumor Phosphoproteomics

Selective optogenetic stimulation of efferent fibers in the vagus nerve of a large mammal.